Crossmark

Safety of tirofiban and dual antiplatelet therapy in treating intracranial aneurysms

Crossref DOI link: https://doi.org/10.1136/svn-2018-000192

Published Online: 2019-02-03

Published Print: 2019-03

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Samaniego, Edgar A

Gibson, Emilee

Nakagawa, Daichi

Ortega-Gutierrez, Santiago

Zanaty, Mario

Roa, Jorge A https://orcid.org/0000-0003-4987-8853
Jabbour, Pascal

Hasan, David M
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct03691727 at ClinicalTrials.gov

Documents that mention this clinical trial

Phase 1/2a Trial of ISPASM
https://doi.org/10.1161/strokeaha.121.034578

Safety of tirofiban and dual antiplatelet therapy in treating intracranial aneurysms
https://doi.org/10.1136/svn-2018-000192
Funding

Funding for this research was provided by:

Medicure